US Stock MarketDetailed Quotes

ENVB Enveric Biosciences

Watchlist
  • 0.3554
  • -0.0027-0.74%
Close Dec 12 16:00 ET
  • 0.3538
  • -0.0016-0.44%
Pre 08:00 ET
3.53MMarket Cap-0.15P/E (TTM)

Enveric Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
66.17%-927.07K
35.31%-2.89M
49.42%-2.6M
17.80%-14.09M
49.42%-1.75M
39.78%-2.74M
2.60%-4.47M
-12.93%-5.14M
-49.65%-17.15M
14.88%-3.46M
Net income from continuing operations
26.16%-2.08M
70.43%-1.88M
47.47%-2.46M
6.39%-17.29M
60.41%-3.44M
-13.85%-2.82M
-127.77%-6.36M
-3.39%-4.68M
62.29%-18.47M
79.39%-8.68M
Operating gains losses
100.10%623
-103.11%-18.57K
88.30%-21.44K
86.14%-1.03M
60.88%-818.4K
80.16%-630.54K
131.18%597.75K
33.63%-183.16K
19.99%-7.46M
7.03%-2.09M
Depreciation and amortization
-11.50%84.81K
-25.88%84.78K
-24.64%85.41K
-6.24%408.03K
-6.57%84.48K
-20.86%95.84K
-4.65%114.37K
9.27%113.33K
-36.15%435.2K
-54.16%90.42K
Deferred tax
----
----
----
--0
----
----
----
----
79.82%-1.5M
----
Other non cash items
----
----
----
--1.85M
----
----
----
----
----
----
Change In working capital
188.11%701.91K
-584.66%-1.45M
39.63%-556.89K
19.71%-174.75K
-72.13%205.84K
-28.44%243.63K
144.17%298.27K
-48.48%-922.49K
-118.37%-217.66K
208.72%738.46K
-Change in prepaid assets
47.63%540.15K
-50.74%215.47K
50.99%-759.29K
98.17%-6.86K
92.31%739.18K
33.75%365.88K
198.74%437.44K
-163.06%-1.55M
-145.24%-374.06K
-24.15%384.36K
-Change in payables and accrued expense
243.52%161.76K
-1,392.22%-1.66M
-69.04%202.4K
-139.38%-103.85K
-244.06%-533.54K
-238.76%-112.71K
42.60%-111.32K
10,757.20%653.71K
-31.19%263.69K
252.70%370.36K
-Change in other working capital
----
----
----
40.31%-64.05K
--199
----
----
---26.85K
---107.29K
----
Cash from discontinued investing activities
Operating cash flow
66.17%-927.07K
35.31%-2.89M
49.42%-2.6M
17.80%-14.09M
49.42%-1.75M
39.78%-2.74M
2.60%-4.47M
-12.93%-5.14M
-49.65%-17.15M
14.88%-3.46M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
102.00%11.67K
99.39%-38
100.11%20
131.27%16.85K
98.98%-5.17K
-126.67%-584.17K
96.74%-6.19K
Net PPE purchase and sale
--0
--0
--0
102.00%11.67K
99.39%-38
100.11%20
131.27%16.85K
98.98%-5.17K
-207.91%-584.17K
96.74%-6.19K
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
102.00%11.67K
99.39%-38
100.11%20
131.27%16.85K
98.98%-5.17K
-126.67%-584.17K
96.74%-6.19K
Financing cash flow
Cash flow from continuing financing activities
593.04%517.69K
103.27%34.43K
6.66M
-107.39%-1.34M
-18,608,300.00%-186.08K
-101.34%-105K
-209.81%-1.05M
0
-26.99%18.18M
-114.29%-1
Net common stock issuance
--517.84K
--51.68K
--4.13M
--0
--0
--0
--0
--0
-20.32%17.22M
---1
Net preferred stock issuance
--0
----
----
---1.05M
--0
--0
----
----
--0
--0
Proceeds from stock option exercised by employees
--0
--0
--2.68M
----
----
--0
--0
--0
----
----
Net other financing activities
---149
---17.25K
---144.06K
-130.38%-291.08K
---186.08K
----
----
----
--958.04K
--0
Cash from discontinued financing activities
Financing cash flow
593.04%517.69K
103.27%34.43K
--6.66M
-107.39%-1.34M
-18,608,300.00%-186.08K
-101.34%-105K
-209.81%-1.05M
--0
-26.99%18.18M
-114.29%-1
Net cash flow
Beginning cash position
-50.54%3.5M
-49.40%6.36M
-87.09%2.29M
2.12%17.72M
-79.88%4.27M
-60.68%7.08M
-42.10%12.56M
2.12%17.72M
999.55%17.36M
-1.15%21.2M
Current changes in cash
85.61%-409.38K
48.11%-2.85M
178.95%4.06M
-3,533.70%-15.43M
44.15%-1.94M
-187.41%-2.85M
-49.44%-5.5M
-218.39%-5.14M
-97.13%449.25K
18.53%-3.47M
Effect of exchange rate changes
-39.44%18.52K
-93.93%1.26K
140.90%8.14K
87.68%-10.02K
-370.16%-41.42K
148.44%30.57K
556.97%20.72K
-305.98%-19.89K
-156.14%-81.36K
-105.35%-8.81K
End cash Position
-27.07%3.11M
-50.54%3.5M
-49.40%6.36M
-87.09%2.29M
-87.09%2.29M
-79.88%4.27M
-60.68%7.08M
-42.10%12.56M
2.12%17.72M
2.12%17.72M
Free cash flow
66.17%-927.07K
35.31%-2.89M
49.47%-2.6M
20.48%-14.1M
49.51%-1.75M
40.02%-2.74M
3.73%-4.47M
-1.74%-5.14M
-43.89%-17.73M
18.53%-3.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 66.17%-927.07K35.31%-2.89M49.42%-2.6M17.80%-14.09M49.42%-1.75M39.78%-2.74M2.60%-4.47M-12.93%-5.14M-49.65%-17.15M14.88%-3.46M
Net income from continuing operations 26.16%-2.08M70.43%-1.88M47.47%-2.46M6.39%-17.29M60.41%-3.44M-13.85%-2.82M-127.77%-6.36M-3.39%-4.68M62.29%-18.47M79.39%-8.68M
Operating gains losses 100.10%623-103.11%-18.57K88.30%-21.44K86.14%-1.03M60.88%-818.4K80.16%-630.54K131.18%597.75K33.63%-183.16K19.99%-7.46M7.03%-2.09M
Depreciation and amortization -11.50%84.81K-25.88%84.78K-24.64%85.41K-6.24%408.03K-6.57%84.48K-20.86%95.84K-4.65%114.37K9.27%113.33K-36.15%435.2K-54.16%90.42K
Deferred tax --------------0----------------79.82%-1.5M----
Other non cash items --------------1.85M------------------------
Change In working capital 188.11%701.91K-584.66%-1.45M39.63%-556.89K19.71%-174.75K-72.13%205.84K-28.44%243.63K144.17%298.27K-48.48%-922.49K-118.37%-217.66K208.72%738.46K
-Change in prepaid assets 47.63%540.15K-50.74%215.47K50.99%-759.29K98.17%-6.86K92.31%739.18K33.75%365.88K198.74%437.44K-163.06%-1.55M-145.24%-374.06K-24.15%384.36K
-Change in payables and accrued expense 243.52%161.76K-1,392.22%-1.66M-69.04%202.4K-139.38%-103.85K-244.06%-533.54K-238.76%-112.71K42.60%-111.32K10,757.20%653.71K-31.19%263.69K252.70%370.36K
-Change in other working capital ------------40.31%-64.05K--199-----------26.85K---107.29K----
Cash from discontinued investing activities
Operating cash flow 66.17%-927.07K35.31%-2.89M49.42%-2.6M17.80%-14.09M49.42%-1.75M39.78%-2.74M2.60%-4.47M-12.93%-5.14M-49.65%-17.15M14.88%-3.46M
Investing cash flow
Cash flow from continuing investing activities 000102.00%11.67K99.39%-38100.11%20131.27%16.85K98.98%-5.17K-126.67%-584.17K96.74%-6.19K
Net PPE purchase and sale --0--0--0102.00%11.67K99.39%-38100.11%20131.27%16.85K98.98%-5.17K-207.91%-584.17K96.74%-6.19K
Cash from discontinued investing activities
Investing cash flow --0--0--0102.00%11.67K99.39%-38100.11%20131.27%16.85K98.98%-5.17K-126.67%-584.17K96.74%-6.19K
Financing cash flow
Cash flow from continuing financing activities 593.04%517.69K103.27%34.43K6.66M-107.39%-1.34M-18,608,300.00%-186.08K-101.34%-105K-209.81%-1.05M0-26.99%18.18M-114.29%-1
Net common stock issuance --517.84K--51.68K--4.13M--0--0--0--0--0-20.32%17.22M---1
Net preferred stock issuance --0-----------1.05M--0--0----------0--0
Proceeds from stock option exercised by employees --0--0--2.68M----------0--0--0--------
Net other financing activities ---149---17.25K---144.06K-130.38%-291.08K---186.08K--------------958.04K--0
Cash from discontinued financing activities
Financing cash flow 593.04%517.69K103.27%34.43K--6.66M-107.39%-1.34M-18,608,300.00%-186.08K-101.34%-105K-209.81%-1.05M--0-26.99%18.18M-114.29%-1
Net cash flow
Beginning cash position -50.54%3.5M-49.40%6.36M-87.09%2.29M2.12%17.72M-79.88%4.27M-60.68%7.08M-42.10%12.56M2.12%17.72M999.55%17.36M-1.15%21.2M
Current changes in cash 85.61%-409.38K48.11%-2.85M178.95%4.06M-3,533.70%-15.43M44.15%-1.94M-187.41%-2.85M-49.44%-5.5M-218.39%-5.14M-97.13%449.25K18.53%-3.47M
Effect of exchange rate changes -39.44%18.52K-93.93%1.26K140.90%8.14K87.68%-10.02K-370.16%-41.42K148.44%30.57K556.97%20.72K-305.98%-19.89K-156.14%-81.36K-105.35%-8.81K
End cash Position -27.07%3.11M-50.54%3.5M-49.40%6.36M-87.09%2.29M-87.09%2.29M-79.88%4.27M-60.68%7.08M-42.10%12.56M2.12%17.72M2.12%17.72M
Free cash flow 66.17%-927.07K35.31%-2.89M49.47%-2.6M20.48%-14.1M49.51%-1.75M40.02%-2.74M3.73%-4.47M-1.74%-5.14M-43.89%-17.73M18.53%-3.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Salesforce
CRM
+0.90%
Apple
AAPL
+0.60%
Cisco
CSCO
+0.44%
Advanced Micro Devices
AMD
+0.35%
Alibaba
BABA
+0.28%

Unlock the Full List